Scribd Logo
Upload

Welcome to Scribd!

  • 292 views

    Drug Study 2

    Uploaded by

    Joshua Selwyn Salazar
    N-acetylcysteine works by splitting mucoproteins in the lungs, reducing viscosity of pulmonary secretions and facilitating removal by coughing or drainage. It is indicated for bronchodilatation before acetylcysteine treatment and protects against acetaminophen overdose hepatotoxicity. Potential side effects include nausea, vomiting, increased secretions or bronchospasm. Nurses should observe the rights of medication administration and monitor the patient's respiratory status and sputum.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Drug Study 2

    Uploaded by

    Joshua Selwyn Salazar
    292 views2 pages
    N-acetylcysteine works by splitting mucoproteins in the lungs, reducing viscosity of pulmonary secretions and facilitating removal by coughing or drainage. It is indicated for bronchodilatation before acetylcysteine treatment and protects against acetaminophen overdose hepatotoxicity. Potential side effects include nausea, vomiting, increased secretions or bronchospasm. Nurses should observe the rights of medication administration and monitor the patient's respiratory status and sputum.

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    N-acetylcysteine works by splitting mucoproteins in the lungs, reducing viscosity of pulmonary secretions and facilitating removal by coughing or drainage. It is indicated for bronchodilatation before acetylcysteine treatment and protects against acetaminophen overdose hepatotoxicity. Potential side effects include nausea, vomiting, increased secretions or bronchospasm. Nurses should observe the rights of medication administration and monitor the patient's respiratory status and sputum.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    292 views2 pages

    Drug Study 2

    Uploaded by

    Joshua Selwyn Salazar
    N-acetylcysteine works by splitting mucoproteins in the lungs, reducing viscosity of pulmonary secretions and facilitating removal by coughing or drainage. It is indicated for bronchodilatation before acetylcysteine treatment and protects against acetaminophen overdose hepatotoxicity. Potential side effects include nausea, vomiting, increased secretions or bronchospasm. Nurses should observe the rights of medication administration and monitor the patient's respiratory status and sputum.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 2

    MECHANISM

    DRUG DATA INDICATIONS / CONTRAINDICATION NURSING RESPONSIBILITIES


    OF ACTION / SIDE EFFECTS
    Generic name: Mechanism of action: Indication: Observe the 10 rights of medication:
     N-acetylcysteine
    Before:
    Splits linkage of mucoproteins, reducing Bronchodilators should be
    Brand name: viscosity of pulmonary secretions.  Assess pretreatment respirations for rate, depth,
    given 10–15 min before acetylcysteine.
     Mucomyst rhythm.
    Therapeutic Effect: Facilitates removal of
    pulmonary secretions by coughing, postural During:
    Classification: drainage, mechanical means. Protects against Contraindication:
     Mucolytic Agent, acetaminophen overdose induced hepatotoxicity  If bronchospasm occurs, discontinue treatment,
    Mucolytics  Large doses may produce severe notify physician; bronchodilator may be added to
    nausea/vomiting. (Less than 2%): Serious therapy. Monitor rate, depth, rhythm, type of
    Patient’s Dose: Side effects: anaphylactoid reactions including cough, respiration (abdominal, thoracic).
     10% (100 mg/ml) wheezing, stridor, respiratory distress,
    Route:  Stickiness on face, transient unpleasant bronchospasm, hypotension, and death After:
     Inhalation, odor. have been known to occur with IV  document and record.
    nebulization (NAS)  Occasional: Inhalation: Increased administration.  Check sputum for color, consistency, amount.
    bronchial secretions, throat irritation,
    Frequency: nausea, vomiting, rhinorrhea.
     q6h  Rare: Inhalation: Rash.

    Adverse effects:

     Large doses may produce severe nausea/


     vomiting.
     (Less than 2%): Serious anaphylactoid
    reactions including cough, wheezing,
    stridor, respiratory distress,
    bronchospasm, hypotension, and death
    MECHANISM
    DRUG DATA INDICATIONS / CONTRAINDICATION NURSING RESPONSIBILITIES
    OF ACTION / SIDE EFFECTS
    Generic name: Mechanism of action: Indication: Observe 10 rights of medication
     dornase alfa
    Before:
    Brand name: Recombinant human DNase 1,  Dornase alfa is indicated for daily
     Pulmozyme digests neutrophil DNA administration in conjunction with  Mucolytic: Assess pretreatment respirations for rate, depth,
    deposited in the pulmonary standard therapies for the management of rhythm.
    Classification: mucosa thereby reducing cystic fibrosis (CF) patients to improve
    pulmonary function. During:
     Enzymes, Mucolytic mucosal viscoelasticity
    Agent  Do not use any other inhaled medicines in the nebulizer at the
    Side effects: Contraindication: same time. Keep all other inhaled medication systems completely
    Patient’s Dose:
    separate from Pulmozyme.
     1mg/mL (2.5mL)  Urticaria, mild to  Hypersensitivity to dornase alfa or Chinese
    Route: moderate, and mild skin hamster ovary cell products  Do not use a mask. Use the mouthpiece provided with each
     Inhalation, rash nebulizer kit.
    nebulization
    After:

    Frequency:  document and record.


     q6h

    You might also like